[1]
ALKA, T. 2025. NOVEL HETEROCYCLIC HYBRIDS AS PROMISING SCAFFOLD FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE. International Journal of Pharmacy and Pharmaceutical Sciences. 17, 2 (Feb. 2025), 1–15. DOI:https://doi.org/10.22159/ijpps.2025v17i2.52596.